Eligibility Pre-Screening

Do you have a medical condition that has lasted more than 3 months?
Have conventional medicines/treatments failed to fully resolve your medical condition or have you avoided treatments due to negative side effects?
This self-assessment is for informational purposes and is not a qualified medical opinion. In case of health emergency, call your local emergency number immediately. By submitting this quiz, you are confirming that you have read and agree to our Terms & Conditions and Privacy Statement.

Is medicinal cannabis for you?

Fast, simple & legal
access in Australia.
Free Eligibility Test

Valens Secures CA$40M Via Credit Facility, Builds Australia Enterprise

Canadian CBD company Valens GroWorks Corp. (TSX: VLNS) (OTCQX: VLNCFconfirmed Monday it has secured up to CA$40 million (US$29 million) in financing via syndicated credit facility.

The agreement between the Kelowna, British Columbia-based company, Canadian Imperial Bank of Commerce and ATB Financial will last three years.

The credit facility includes CA$20 million of secured term loan and CA$20 million of secured revolving loan. Under the deal, Valens is granted up to an additional CA$10 million if it decides to raise aggregate commitments.

“With our enhanced balance sheet, we are well positioned to continue to expand our innovative product portfolio, build out our custom manufacturing platform, be opportunistic in a consolidating market and maximize capital allocation to generate the highest return on invested capital for our shareholders,” said Valens CEO Tyler Robson in a statement.

The company said it would utilize funds for expansion of its operations and corporate strategy development.

Own the Top-Performing Breakout Stock Every Month?

We all want to own breakout stocks every month. The only problem is finding them takes too long. Until now.

Benzinga’s Breakout Opportunity Letter sends you the name and ticker symbol of a breakout stock every month. Best of all, you can subscribe today with a special introductory offer.

Please read the full article here.

Leave Comments

Your email address will not be published. Required fields are marked *